Literature DB >> 10371188

Effects of metformin on insulin resistance and central adiposity in patients receiving effective protease inhibitor therapy.

T Saint-Marc, J L Touraine.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10371188     DOI: 10.1097/00002030-199905280-00023

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  21 in total

1.  [HALS: HIV-Lipodystrophy associated syndrome].

Authors:  S Hilton; S Mauss; T Ruzicka; D Bruch-Gerharz
Journal:  Hautarzt       Date:  2005-04       Impact factor: 0.751

2.  Protease inhibitor-induced diabetic complications : incidence, management and prevention.

Authors:  Lillian F Lien; Mark N Feinglos
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 3.  The effects of HIV protease inhibitors on carbohydrate and lipid metabolism.

Authors:  Grace A Lee; Madhu N Rao; Carl Grunfeld
Journal:  Curr HIV/AIDS Rep       Date:  2005-02       Impact factor: 5.071

Review 4.  HIV-associated lipodystrophy: description, pathogenesis, and molecular pathways.

Authors:  Patrick W G Mallon; Andrew Carr; David A Cooper
Journal:  Curr Diab Rep       Date:  2002-04       Impact factor: 4.810

Review 5.  Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management.

Authors:  Absalon D Gutierrez; Ashok Balasubramanyam
Journal:  Endocrine       Date:  2011-12-02       Impact factor: 3.633

Review 6.  Insulin resistance in HIV-related lipodystrophy.

Authors:  Nasser Mikhail
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

Review 7.  Metformin: new understandings, new uses.

Authors:  Ripudaman S Hundal; Silvio E Inzucchi
Journal:  Drugs       Date:  2003       Impact factor: 9.546

8.  The efficacy and safety of insulin-sensitizing drugs in HIV-associated lipodystrophy syndrome: a meta-analysis of randomized trials.

Authors:  Siddharth H Sheth; Robin J Larson
Journal:  BMC Infect Dis       Date:  2010-06-23       Impact factor: 3.090

9.  Effect of rosiglitazone and metformin on insulin resistance in patients infected with human immunodeficiency virus receiving highly active antiretroviral therapy containing protease inhibitor: randomized prospective controlled clinical trial.

Authors:  Anja Silic; Andrej Janez; Janez Tomazic; Primoz Karner; Ludvik Vidmar; Prem Sharma; Mojca Maticic
Journal:  Croat Med J       Date:  2007-12       Impact factor: 1.351

Review 10.  Approach to the human immunodeficiency virus-infected patient with lipodystrophy.

Authors:  Todd T Brown
Journal:  J Clin Endocrinol Metab       Date:  2008-08       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.